GA_P advises Labiana Health on the capital increase carried out as part of the full refinancing of its debt

Gómez-Acebo & Pombo has advised Labiana Health, a pharmaceutical company specialising in animal and human health and whose shares are listed on BME Growth, on the capital increase carried out as a condition precedent to a €37 million syndicated financing aimed at refinancing the company’s total indebtedness. The financing was led by Deutsche Bank Spain as facility agent, together with Institut Català de Finances (ICF), Andorra Banc Agrícol Reig, CaixaBank and Banco Santander.

The capital increase was completed for an amount of €5.072 million, through the issuance of 1,268,000 new ordinary shares at a price of €4 per share, with pre‑emptive subscription rights granted to existing shareholders.

The advice also covered the refinancing transaction, which involved the full replacement of the existing alternative financing structure, including the repayment of the financing granted by Miralta Bank, S.A. and Blantyre Capital Limited, with a long‑term syndicated banking framework, featuring a progressive amortisation schedule and more extended and orderly maturities, prioritising cash generation and eliminating instruments with potential dilutive effects for shareholders.  

The GA_P team comprised Augusto Piñel, together with Jacobo Palanca and Irene Carreño Uría, partner and associates from the Corporate and Capital Markets teams.

Ver noticia